Great Tree Pharmacy : Board of Directors resolved to conduct private placement of domestic convertible corporate bonds

Close

Today's Information

Provided by: Great Tree Pharmacy Co.,Ltd.
SEQ_NO	2	Date of announcement	2022/04/06	Time of announcement	19:53:27
Subject	Great Tree Pharmacy Co., Ltd.'s Board of Directors resolved to conduct private placement of domestic convertible corporate bonds
Date of events	2022/04/06	To which item it meets	paragraph 11
Statement	1.Date of the board of directors resolution:2022/04/06 2.Name of the corporate bonds: Domestic convertible corporate bonds in private placement 3.Total amount issued: It will be proposed for the sahreholders meeting to authorize the Board of Directors to choose appropriate timing and fund fundrasising instrument(s) by one or a combination of methods:conduct private placement of common shares and/or conduct private placement of domestic convertible corporate bonds, within the limit of 2 million common shares, depending on the market conditions and the Company's needs, in accordance with the applicable laws and regulations and the following fund raising method principles. When domestic convertible corporate bonds are issued through privated placement, the number of common shares that can be converted from privately placed convertible corporate bonds shall be within the aforementioned scopoe of 2 million shares, and shall be calculated in accordance with the conversion price determined at the time of private placement. 4.Face value per bond: par value of NT$100,000 5.Issue price: The issue price shall be no less than 80% of the theoretical price. 6.Issuance period: The Board of Directors is authorized to determine this. 7.Coupon rate: The Board of Directors is authorized to determine this. 8.Types, names, monetary values and stipulations of collaterals: N/A 9.Use of the funds raised by the offering and utilization plan: The funds raised hereby shall serve to either increase working capital, strengthen the financial structure and support the company to expand its marketing channels increase its market share. 10.Trustees of the corporate bonds: N/A 11.Guarantor(s) for the issuance: N/A 12.Agent for payment of the principal and interest: N/A 13.Where convertible into shares, the price and the rules for conversion: The Board of Directors is authorized to determine this. 14.Sell-back conditions: The Board of Directors is authorized to determine this. 15.Buyback conditions: The Board of Directors is authorized to determine this. 16.Reference date for any additional share exchange, stock swap, or subscription: N/A 17.Possible dilution of equity in case of any additional share exchange, stock swap, or subscription: N/a 18.For additional share exchange or subscription, possible influence of change in shareholding ratio of TPEx-listed common shares if all privately placed corporate bonds are converted and shares subscribed for (no.of TPEx -listed common shares (a), (a) / outstanding common shares): N/A 19.Please explain any countermeasures for lower circulation in shareholding if the aforesaid estimated no.of TPEx-listed common shares does not reach 5 million and the ratio does not reach 25%: N/A 20.Any other matters that need to be specified: (1)Except for the transfer restriction regulated by Article 43-8, Securities and Exchange Act, the rights and obligations of the new privately placed common shares converted from domestic convertible bonds are the same as the issued common shares. Privately placed securities in principle may not be transferred and may be filed with the Competent Authority for retroactive hadling of public issuance procedures and listing where three full years have elapsed since the delivery date. (2)It will be submitted to a shareholders meeting that the Chairman is authorized with full power to adjust, determine, and conduct the important part of the plan for privately placed domestic convertible bonds, such as terms and conditions of issuance, praticluars of the plan, funds to be raised, the purpose of the funds, implementation schedule, and expected returns, and so on, due to the instruction or requirement from the Competent Authority or to the necessary amendment or adjustment in response to objective factors. Besides the aforementioned authorization, the Chaiman intends to obtain the authorization by a shareholders meeting to sing and negotiate the contracts and documents related to this private placement plan on behalf of the Company and to hadle all matters for this private placement plan.